LY231514
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for LY231514, covering 2012-06-28 to 2016-12-07. Get the full timeline:
Most recent: Clinical Trial Update: LY231514 Plus Gemcitabine in Treating Women With Metastatic Breast Cancer [Phase 2]